-
Mashup Score: 0ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation - 10 month(s) ago
Anumana has received breakthrough device designation from the US Food and Drug Administration (FDA) for its electrocardiogram (ECG) artificial intelligence (AI) algorithm designed to aid the early identification of cardiac amyloidosis.
Source: Cardiac Rhythm NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir dual chamber (DR) leadless pacemaker system, described by the company as the world’s first dual chamber leadless pacing system for the treatment of abnormal heart rhythms.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ADVERTORIAL: Mapping integrated PFA catheter produces “never before” seen outcomes for the treatment of atrial fibrillation - Cardiac Rhythm News - 10 month(s) ago
“The simplicity, the efficacy and the safety” of pulsed field ablation (PFA) in the treatment of atrial fibrillation (AF) could not be…
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0AI model can allow for interpretation of ECGs as language - 11 month(s) ago
Researchers have developed an artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Research highlights “strikingly low” use of public defibrillators in cardiac arrest - Cardiac Rhythm News - 11 month(s) ago
Defibrillators are being used in just one in 10 cardiac arrests where they are available, according to research presented at the British Cardiovascular Society Conference (5–7 June, Manchester, UK). The research drew upon data from the East of England Ambulance Service and The Circuit, the national defibrillator network developed by the British Heart Foundation (BHF). […]
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Healthy or hazardous: Study raises “red flag” on wearable smart device interference with CIEDs - Cardiac Rhythm News - 1 year(s) ago
New “red flag-raising” study has provided benchmark data on the safety of smart devices with bioimpedance technology for patients with CIEDs.
Source: Cardiac Rhythm NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Healthy or hazardous: Study raises “red flag” on wearable smart device interference with CIEDs - Cardiac Rhythm News - 1 year(s) ago
New “red flag-raising” study has provided benchmark data on the safety of smart devices with bioimpedance technology for patients with CIEDs.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Accelerated pacing rate benefits HFpEF patients with pacemakers - Cardiac Rhythm News - 1 year(s) ago
Among patients with HFpEF and a pacemaker, treatment with a moderately accelerated, personalised pacing rate resulted in an improved quality of life, NT-proBNP levels, and AF compared to the nominal setting of 60 beats per minute.
Source: Cardiac Rhythm NewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Cardiology societies urge rethink of randomised controlled trial design - Cardiac Rhythm News - 1 year(s) ago
The current model for randomised clinical trials must be redesigned for the modern age, according to the European Society of Cardiology (ESC), American Heart Association (AHA), World Heart Federation (WHF) and American College of Cardiology (ACC). The call comes in a joint statement which has been published simultaneously in the flagship journals of all four […]
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Kardium has announced the successful first-in-human study of its next generation Globe pulsed field system to treat atrial fibrillation (AF) using pulsed field ablation (PFA) therapy.
Source: Cardiac Rhythm NewsCategories: Cardiology News and Journals, Latest HeadlinesTweet
ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation https://t.co/i7dJ7ghA7v #amyloid #AI #ECG #CardioTwitter via @CRN_publishing